Capital Group Investment Management Pte. Ltd. Astrazeneca PLC Transaction History
Capital Group Investment Management Pte. Ltd.
- $444 Million
- Q2 2024
A detailed history of Capital Group Investment Management Pte. Ltd. transactions in Astrazeneca PLC stock. As of the latest transaction made, Capital Group Investment Management Pte. Ltd. holds 8,496 shares of AZN stock, worth $606,869. This represents 0.15% of its overall portfolio holdings.
Number of Shares
8,496
Previous 8,444
0.62%
Holding current value
$606,869
Previous $572,000
15.73%
% of portfolio
0.15%
Previous 0.11%
Shares
3 transactions
Others Institutions Holding AZN
# of Institutions
1,348Shares Held
492MCall Options Held
4.99MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD64.9MShares$4.64 Billion0.61% of portfolio
-
Primecap Management CO Pasadena, CA42.6MShares$3.04 Billion2.44% of portfolio
-
Wellington Management Group LLP Boston, MA40.6MShares$2.9 Billion0.58% of portfolio
-
Capital International Investors Los Angeles, CA36.7MShares$2.62 Billion0.6% of portfolio
-
Franklin Resources Inc San Mateo, CA17.6MShares$1.26 Billion0.44% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $221B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...